Bal Pharma reports consolidated net loss of Rs 2.46 crore in the June 2019 quarter
Sales decline 8.23% to Rs 49.16 crore
Net loss of Bal Pharma reported to Rs 2.46 crore in the quarter ended June 2019 as against net profit of Rs 1.58 crore during the previous quarter ended June 2018. Sales declined 8.23% to Rs 49.16 crore in the quarter ended June 2019 as against Rs 53.57 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales49.1653.57 -8 OPM %3.237.22 -PBDT-1.471.97 PL PBT-2.790.53 PL NP-2.461.58 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content